知镜 Cognispect · 医学文献与研究工作台

Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard.

Schuetz JD, Kim RB.
Clinical pharmacology and therapeutics · 2026-11-08 · PMID 43000227

文献摘要

Genomic findings can sharpen therapeutic decisions, but they can also provide false reassurance. In precision oncology, labels such as benign, nonactionable, or explanatory may be mistaken for evidence that symptoms or abnormal findings require no further evaluation. This Perspective argues that genotype-phenotype discordance should be treated as a safety signal. Simple report language, tumor-board checks, and artificial intelligence guardrails can preserve the value of genomics without allowing a molecular explanation to become diagnostic closure.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。